Form 8-K - Current report:
SEC Accession No. 0001520138-21-000643
Filing Date
2021-10-14
Accepted
2021-10-14 08:02:59
Documents
12
Period of Report
2021-10-13
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT bivi-20211013_8k.htm   iXBRL 8-K 44647
  Complete submission text file 0001520138-21-000643.txt   218216

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE bivi-20211013.xsd EX-101.SCH 3046
3 XBRL LABEL FILE bivi-20211013_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE bivi-20211013_pre.xml EX-101.PRE 22373
5 EXTRACTED XBRL INSTANCE DOCUMENT bivi-20211013_8k_htm.xml XML 3603
Mailing Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404
Business Address 2120 COLORADO AVE. SUITE 230 LOS ANGELES CA 90404 310-444-4300
BIOVIE INC. (Filer) CIK: 0001580149 (see all company filings)

EIN.: 462510769 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39015 | Film No.: 211322510
SIC: 2834 Pharmaceutical Preparations